Could a simple health chat slash heart disease and cancer risk?

NCT ID NCT04912739

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial tests whether personalized health dialogues, combined with lifestyle screening and molecular profiling, can reduce the risk of cardiovascular disease, cancer, and other serious conditions. Adults aged 40, 50, 60, and 70 in Sweden's Skåne region will participate. They will complete questionnaires, have clinical measurements taken, and discuss their results with trained healthcare personnel. The study will track health outcomes over time to see if this approach leads to earlier detection and better prevention.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Targeted health dialogues with lifestyle screening and molecular profiling
What this could lead to
If effective, this could lead to a more personalized prevention program that reduces the risk of cardiovascular disease and cancer in middle-aged adults.
What could go wrong
The trial is observational in part and relies on comparisons with historical controls, which may limit the strength of conclusions. The intervention's success depends on long-term adherence and behavior change.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Center for Primary Health Care Research, Lund University and Region Skåne

    RECRUITING

    Malmö, Skåne County, 20502, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.